Fixed-ratio combination of basal insulin and GLP-1 receptor agonist: is two better than one?

被引：1
作者：
Del Prato, Stefano [1 ]
机构：
[1] Univ Pisa, Dept Clin & Expt Med, Sect Diabet & Metab Dis, I-56124 Pisa, Italy
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2014年 / 2卷 / 11期
关键词：
D O I：
10.1016/S2213-8587(14)70185-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：856 / 858
页数：4
相关论文
共 10 条
[1]  
[Anonymous], INT J OBESITY
[2]   Minireview: IGF, Insulin, and Cancer [J].
Gallagher, Emily J. ;
LeRoith, Derek .
ENDOCRINOLOGY, 2011, 152 (07) :2546-2551
[3]   Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia [J].
Gerstein, Hertzel C. ;
Bosch, Jackie ;
Dagenais, Gilles R. ;
Diaz, Rafael ;
Jung, Hyejung ;
Maggioni, Aldo P. ;
Pogue, Janice ;
Probstfield, Jeffrey ;
Ramachandran, Ambady ;
Riddle, Matthew C. ;
Ryden, Lars E. ;
Yusuf, Salim .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (04) :319-328
[4]  
Gough SC, 2014, LANCET DIABETES ENDO
[5]   Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings [J].
Holst, J. J. ;
Vilsboll, T. .
DIABETES OBESITY & METABOLISM, 2013, 15 (01) :3-14
[6]   Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [J].
Inzucchi, S. E. ;
Bergenstal, R. M. ;
Buse, J. B. ;
Diamant, M. ;
Ferrannini, E. ;
Nauck, M. ;
Peters, A. L. ;
Tsapas, A. ;
Wender, R. ;
Matthews, D. R. .
DIABETOLOGIA, 2012, 55 (06) :1577-1596
[7]   Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future [J].
Kahn, Steven E. ;
Cooper, Mark E. ;
Del Prato, Stefano .
LANCET, 2014, 383 (9922) :1068-1083
[8]   Vasculotoxic Effects of Insulin and Its Role in Atherosclerosis: What is the Evidence? [J].
Nandish, Shailesh ;
Bailon, Oscar ;
Wyatt, Jamison ;
Smith, John ;
Stevens, Adrienne ;
Lujan, Mike ;
Chilton, Robert .
CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (02) :123-128
[9]   Intensive insulin for type 2 diabetes: the risk of causing harm [J].
Nolan, Christopher J. ;
Ruderman, Neil B. ;
Prentki, Marc .
LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (01) :9-10
[10]   Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK [J].
Rubino, A. ;
McQuay, L. J. ;
Gough, S. C. ;
Kvasz, M. ;
Tennis, P. .
DIABETIC MEDICINE, 2007, 24 (12) :1412-1418
1